Understanding Retroviral Gag and RNA Targeting and Virus Assembly
了解逆转录病毒 Gag 和 RNA 靶向以及病毒组装
基本信息
- 批准号:9153589
- 负责人:
- 金额:$ 62.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Cell NucleusCell membraneComplexCytoplasmDiffusionEventGaggingHIVHIV Drug Resistance ProgramHIV-1Imaging DeviceLengthLocationPropertyRNARNA TransportReportingResearchSite VisitSynapsesT-LymphocyteTestingTimeTranslatingViralVirusVirus Assemblymacromoleculemacrophagemembrane assemblyprogramsresearch studytrafficking
项目摘要
We have examined the complex interactions needed for generating an infectious virus. We are studying the trafficking of HIV-1 macromolecules and assembly. Once exported from the nucleus, HIV-1 RNA needs to traffic to proper subcellular locations to be translated or packaged; similarly, the newly synthesized Gag needs to be targeted to the plasma membrane for virus assembly. Using our newly developed imaging tools, we have determined that HIV-1 RNA uses diffusion as the major mechanism for transport. HIV-1 RNA traffics to the plasma membrane for assembly; we will investigate the properties of this targeting event, including whether monomeric or dimeric RNA is targeted during assembly and the dwell time of the RNA that stays near the plasma membrane. We are currently testing the hypothesis that Gag-dimeric RNA interaction is the nucleation point of retroviral assembly. We are investigating Gag and RNA targeting in polarized T cells and in viral synapses. These experiments will provide an understanding of aspects of HIV-1 replication that we currently know very little about and will allow us to better understand how HIV-1 uses the cellular machinery to traffic its macromolecules. [Corresponds to Hu Project 3 in the October 2011 site visit report of the HIV Drug Resistance Program, renamed the HIV Dynamics and Replication Program in 2015]
我们已经研究了产生传染性病毒所需的复杂相互作用。我们正在研究HIV-1大分子的贩运和组装。一旦从细胞核输出,HIV-1 RNA需要运输到适当的亚细胞位置进行翻译或包装;同样,新合成的Gag需要靶向质膜进行病毒组装。使用我们新开发的成像工具,我们已经确定HIV-1 RNA使用扩散作为主要的运输机制。HIV-1 RNA运输到质膜进行组装;我们将研究这种靶向事件的性质,包括组装过程中是否靶向单体或二聚体RNA以及RNA在质膜附近的停留时间。我们目前正在测试的假设,GAG二聚体RNA的相互作用是逆转录病毒装配的成核点。我们正在研究极化T细胞和病毒突触中的Gag和RNA靶向。这些实验将提供对HIV-1复制方面的理解,我们目前对此知之甚少,并将使我们更好地了解HIV-1如何使用细胞机制来运输其大分子。[对应于2011年10月艾滋病毒耐药性项目(2015年更名为艾滋病毒动态和复制项目)现场访问报告中的Hu项目3]
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WEI-SHAU HU其他文献
WEI-SHAU HU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WEI-SHAU HU', 18)}}的其他基金
DISSECTING THE MECHANISMS OF RETROVIRAL RECOMBINATION
剖析逆转录病毒重组机制
- 批准号:
2008143 - 财政年份:1993
- 资助金额:
$ 62.08万 - 项目类别:
DISSECTING THE MECHANISMS OF RETROVIRAL RECOMBINATION
剖析逆转录病毒重组机制
- 批准号:
2099058 - 财政年份:1993
- 资助金额:
$ 62.08万 - 项目类别:
DISSECTING THE MECHANISMS OF RETROVIRAL RECOMBINATION
剖析逆转录病毒重组机制
- 批准号:
3460620 - 财政年份:1993
- 资助金额:
$ 62.08万 - 项目类别:
DISSECTING THE MECHANISMS OF RETROVIRAL RECOMBINATION
剖析逆转录病毒重组机制
- 批准号:
2099059 - 财政年份:1993
- 资助金额:
$ 62.08万 - 项目类别:
DISSECTING THE MECHANISMS OF RETROVIRAL RECOMBINATION
剖析逆转录病毒重组机制
- 批准号:
2099057 - 财政年份:1993
- 资助金额:
$ 62.08万 - 项目类别:
Understanding Retroviral Reverse Transcription, Recombination, and Replication
了解逆转录病毒逆转录、重组和复制
- 批准号:
10702365 - 财政年份:
- 资助金额:
$ 62.08万 - 项目类别:
Defining Mechanisms of HIV-1 Gag:RNA Interactions and Virus Assembly
HIV-1 Gag 的定义机制:RNA 相互作用和病毒组装
- 批准号:
10702366 - 财政年份:
- 资助金额:
$ 62.08万 - 项目类别:
相似海外基金
Discovery of cell membrane permeable HDAC6 PROTACs
细胞膜渗透性 HDAC6 PROTAC 的发现
- 批准号:
23K06061 - 财政年份:2023
- 资助金额:
$ 62.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Control of cell membrane permeability by intense electrical pulses and development of innovative food processing
通过强电脉冲控制细胞膜渗透性和创新食品加工的发展
- 批准号:
23H01403 - 财政年份:2023
- 资助金额:
$ 62.08万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a method to inhibit epithelial-mesenchymal transition by targeting cell membrane phospholipids
开发一种通过靶向细胞膜磷脂抑制上皮间质转化的方法
- 批准号:
23K06103 - 财政年份:2023
- 资助金额:
$ 62.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Host cell membrane perforation during invasion by Toxoplasma gondii
弓形虫入侵过程中宿主细胞膜穿孔
- 批准号:
10587658 - 财政年份:2023
- 资助金额:
$ 62.08万 - 项目类别:
Cell membrane-targeting proteoglycan chimeras as selective growth factor signaling actuators
作为选择性生长因子信号传导执行器的细胞膜靶向蛋白聚糖嵌合体
- 批准号:
10588085 - 财政年份:2023
- 资助金额:
$ 62.08万 - 项目类别:
High throughput antibody discovery against cell membrane bound target proteins using innovative MOD technology for direct screening in single-cell assays
使用创新的 MOD 技术发现针对细胞膜结合靶蛋白的高通量抗体,用于单细胞测定中的直接筛选
- 批准号:
10698891 - 财政年份:2023
- 资助金额:
$ 62.08万 - 项目类别:
Probing the specific interactions of AlphaA- crystallin and its aging- and cataract-associated forms with lens cell membrane mimics
探讨 AlphaA-晶状体蛋白及其与衰老和白内障相关的形式与晶状体细胞膜模拟物的特定相互作用
- 批准号:
10667060 - 财政年份:2023
- 资助金额:
$ 62.08万 - 项目类别:
Three-dimensional measurement of cell-sercreted molecules using probe-type artificial cell membrane systems
使用探针型人工细胞膜系统对细胞分泌分子进行三维测量
- 批准号:
23H01822 - 财政年份:2023
- 资助金额:
$ 62.08万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
An extedned research of cell membrane domains based on the probes of membrane molecules
基于膜分子探针的细胞膜域扩展研究
- 批准号:
22H00359 - 财政年份:2022
- 资助金额:
$ 62.08万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Nanostructure transfer to cell membrane by cytoplasmic gelation and its optical sensor application
细胞质凝胶化纳米结构转移至细胞膜及其光学传感器应用
- 批准号:
22K18760 - 财政年份:2022
- 资助金额:
$ 62.08万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)